Skip to main content
Clinical Trials/NCT06245720
NCT06245720
Active, not recruiting
Not Applicable

Serum and Urine Metabolome Studies in Patients With Acute Kidney Injury After Cardiac Surgery

Nanjing First Hospital, Nanjing Medical University1 site in 1 country200 target enrollmentJanuary 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Surgery Associated Acute Kidney Injury
Sponsor
Nanjing First Hospital, Nanjing Medical University
Enrollment
200
Locations
1
Primary Endpoint
serum and urine metabolome studies
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this observational study is to learn about serum and urine metabolome in patients after cardiac surgery.

Detailed Description

The main objective of this study is to collect blood and urine samples from patients after cardiac surgery, and to perform metabolomic analysis to find the differential metabolites and their enrichment pathways in AKI patients and non-AKI patients.The secondary objective is to intervene in its enrichment pathway to find ways to improve CSA-AKI.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
December 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age\> 18 years old;
  • after cardiopulmonary bypass;

Exclusion Criteria

  • Under the age of 18;
  • Previous chronic kidney disease or receiving renal replacement therapy;
  • Have a history of kidney transplantation or nephrectomy.

Outcomes

Primary Outcomes

serum and urine metabolome studies

Time Frame: January 2025 - December 2025

The preoperative and postoperative metabolomic differences in blood and urine between AKI group and non-AKI group were compared.

Study Sites (1)

Loading locations...

Similar Trials